Brachytherapy for Prostate Cancer 2017

• Peer review evidence based trees estimate:

RP: 24% (15-30) EBRT: 58% (54-64%) BT: 9.6% (6-17.9%)

• Actual utilisations rates:

RP: 13-44% EBRT: 43-56% BT: 1.8-10.9%